Hall 2

Hall 3

ساعت برگزاریموضوع بحثسخنرانی هانام سالن
14:00-15:15Current markers in immunotherapy
The value of PD-L1 as a biomarker beyond lung cancers (ID 34)
Lecture Time
14:00 - 14:25
Speakers

K. Harrington (London, United Kingdom)

Educational session
The clonal evolution and its impact on immunotherapy (ID 35)
Lecture Time
14:25 - 14:50
Speakers

S. Turajlic (London, United Kingdom)

Educational session
Targeting the microenvironment (ID 33)
Lecture Time
14:50 - 15:15
Speakers

W. Fridman (, United States of America)

Educational session
Discussion (ID 382)
Lecture Time
15:15 - 15:30
سالن الف
16:00-19:30The clinical utility of analysing circulating tumor DNA in patients with colorectal cancer (CRC)
The value of PD-L1 as a biomarker beyond lung cancers (ID 34)
Lecture Time
14:00 - 14:25
Speakers

K. Harrington (London, United Kingdom)

Educational session
The clonal evolution and its impact on immunotherapy (ID 35)
Lecture Time
14:25 - 14:50
Speakers

S. Turajlic (London, United Kingdom)

Educational session
Targeting the microenvironment (ID 33)
Lecture Time
14:50 - 15:15
Speakers

W. Fridman (, United States of America)

Educational session
Discussion (ID 382)
سالن ب
TitleHall Time SessionsSpeakers
8:00-10:25
موضوع اصلی بحث این بخش کنفرانس در این ردیف نوشته شود
سالن شماره یک

8:00 – 9:30Welcome and registration-
9:45– 9:50Foreword-
-
9:55 – 10:25
The status of radiotherapy in Iran and development timeline
10:30-12:50
موضوع اصلی بحث این بخش کنفرانس در این ردیف نوشته شود
سالن شماره دو10:30 – 11:15
Developing which advanced RT techniques is a priority?
11:15 – 11:30Coffee break
11:30 – 12:15Advanced radiotherapy in developing countries (1): Chain of hindrances
12:20 – 12:50
Advanced radiotherapy in developing countries (2): Cultural hindrances
12:50 – 14:00
Lunch break
14:00-17:50
موضوع اصلی بحث این بخش کنفرانس در این ردیف نوشته شود
سالن شماره سوم14:00 – 14:45
Advanced radiotherapy in developing countries (3): Investments and outcomes
14:50 – 15:25Towards safer treatments: The role of national regulatory agencies
15:30 – 16:15

What to do for embarking on advanced RT? real case scenario (the chain: linacs; IT; imaging; training; costs; purchases; procedures; min req.)
16:20 – 17:50

Panel (i): Recap and what next?
(quality management program; workflow)
(Pre-defined questions)
17:50
Refreshments